2021-2024 Strategic Plan
Message from the President & CEO, Michael Osso
2021 will be a year of transition for the Crohn’s & Colitis Foundation, and for the rest of the world, as we forge a new way forward out of the COVID-19 pandemic. This makes us even more excited about the opportunity to be launching a new strategic plan, building on our learnings from the past plan and the past year, and developing a clear roadmap for the future.
Despite the many challenges of 2020, we see a path towards progress on all sides. On the mission side, we are taking on critical challenges such as improving remission rates, increasing access to care, and advancing new therapies and innovative products. On the revenue side, we are committed to becoming a $100 million organization within the next four years.
In this plan, you will see that there are several changes from the past, and yet a number of things have remained the same. Our commitment to our core constituents – patients, caregivers, donors, partners, researchers, and healthcare practitioners – is stronger than ever. And at the Foundation, we will be going about our work in an ever-more-integrated and data-driven fashion, with all parts of the Foundation and the inflammatory bowel disease (IBD) community working together to achieve our collective goals. With our increased focus on impact and metrics, we will be able to report back progress against our goals in a more regular and concrete fashion.
Importantly, as an organization that is focused on improving the quality of life of all IBD patients and caregivers, we clearly recognize that diversity and inclusion are necessary to achieve our mission. Inequality and racial injustice have been at the forefront of our national conversation, and continue to lead to racial disparities in healthcare. The Crohn’s & Colitis Foundation is committed to advancing the efforts of diversity and inclusion within the internal and external scope of the organization through this new strategic plan. Through our work in education, support, and advocacy, we are invested in ensuring diverse communities receive the latest IBD information and resources tailored to each population’s need. In our research, we recognize the importance of addressing race in research on the diagnosis and treatment of IBD patients. Furthermore, we are deeply committed to creating a truly inclusive environment in our own workplace, in a way that is also reflective of the diverse patient population we serve. You can find more information on our current diversity efforts here, and you will see much of this commitment embedded in various strategic initiatives throughout the following plan.
I am looking forward to moving this new strategic plan ahead, and I hope you will join me and all my colleagues at the Foundation as we advance towards our ultimate goal - cures for Crohn’s disease and ulcerative colitis.
President & CEO
Strategic Plan overview
The Crohn's & Colitis Foundation is guided by a strategic plan that we develop every four years with significant input from our stakeholders: our staff, volunteers, donors, partners, healthcare professionals, researchers, patients, and caregivers. We view the strategic planning process as a very serious responsibility, ensuring that our resources, expertise, and leadership role within the IBD Community are strategically focused on our diverse community's most urgent needs.
The 2021-2024 strategic plan builds on the previous plan, which guided the Foundation from 2017-2020. The Objectives and Strategies will drive our decisions over the next four years as we allocate resources towards our most important priorities and areas with the greatest opportunities for significant positive impact on our community. Importantly, this strategic plan is also driven by our mission, our core values, and some very important guiding principles, all of which are discussed below.
The strategic plan is divided into our two most essential pillars: Mission and Revenue. Our Mission work drives everything we do, every day. It’s the reason we get up in the morning, and it’s the reason we fundraise. But achieving our Revenue objectives is the only way we will be able to achieve our Mission, so these are inextricably linked.
In fact, Objective 1 of our Revenue pillar could easily have been part of our Mission pillar, because its focus – expanding our reach (in other words, helping more patients and caregivers find the support and resources that are available to them through the Foundation) – is an important route to helping improve the quality of life of children and adults who are affected by IBD. As such, our organization must focus on both Mission and Revenue to achieve our ultimate vision – a world without IBD.
Mission and values
The mission of the Crohn's & Colitis Foundation is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults affected by these diseases.
Our Core Values
Compassion, Integrity, Leadership, Collaboration, and Inclusion. Read more about these here.
Read more about our essential pillars and principles below: